| P50 | author | Sarah E Bohndiek | Q56459400 |
| P2093 | author name string | Sanjiv S Gambhir | |
| | Jesse V Jokerst | |
| | Steven Machtaler | |
| | Laura S Sasportas | |
| | Sharon Hori | |
| P2860 | cites work | Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning | Q24310148 |
| | Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis | Q24313372 |
| | Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels | Q24644150 |
| | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| | Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2 | Q28570936 |
| | Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 |
| | Photoacoustic imaging of vascular hemodynamics: validation with blood oxygenation level-dependent MR imaging | Q30387367 |
| | Light in and sound out: emerging translational strategies for photoacoustic imaging | Q30418747 |
| | Photoacoustic microscopy: a potential new tool for evaluation of angiogenesis inhibitor | Q30446411 |
| | Non-invasive imaging for studying anti-angiogenic therapy effects. | Q30447988 |
| | Photoacoustic tomography: in vivo imaging from organelles to organs | Q30456098 |
| | Photoacoustic angiography of the breast | Q30473338 |
| | Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization | Q30477398 |
| | Coregistered three-dimensional ultrasound and photoacoustic imaging system for ovarian tissue characterization | Q30479749 |
| | Imaging and 'omic' methods for the molecular diagnosis of cancer | Q33577268 |
| | Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth | Q33732486 |
| | Hyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization. | Q34120237 |
| | Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody | Q35604097 |
| | Angiogenesis in normal and neoplastic ovaries | Q36279903 |
| | Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system | Q37398561 |
| | Beyond chemotherapy: targeted therapies in ovarian cancer | Q37399899 |
| | Ovarian cancer: the duplicity of CA125 measurement | Q37724570 |
| | Targeting the ANGPT-TIE2 pathway in malignancy | Q37774852 |
| | Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer | Q37977847 |
| | Vascular permeability and drug delivery in cancers | Q38130686 |
| | In vivo preclinical photoacoustic imaging of tumor vasculature development and therapy | Q39345321 |
| | Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth | Q39885086 |
| | Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer | Q40488126 |
| | An in vivo mouse reporter gene (human secreted alkaline phosphatase) model to monitor ovarian tumor growth and response to therapeutics | Q40657898 |
| | Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice | Q44123642 |
| | Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors | Q44649604 |
| | Seasonal variation in litter size, bodyweight and sexual maturation in juvenile female house mice (Mus musculus) | Q47328490 |
| | Optical imaging of cancer heterogeneity with multispectral optoacoustic tomography. | Q50498770 |
| | Visualizing breast cancer using the Twente photoacoustic mammoscope: what do we learn from twelve new patient measurements? | Q53155950 |
| | Increased vascularization in mice overexpressing angiopoietin-1 | Q77418701 |
| | Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer | Q83069293 |
| | Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition | Q85428242 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis inhibitor | Q574834 |
| | photoacoustics | Q63443180 |
| P304 | page(s) | 1942-1947 | |
| P577 | publication date | 2015-08-27 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | Photoacoustic Tomography Detects Early Vessel Regression and Normalization During Ovarian Tumor Response to the Antiangiogenic Therapy Trebananib | |
| P478 | volume | 56 | |